| Title: |
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study |
| Authors: |
Yimer, Habte; Melear, Jason; Faber, Edward; Bensinger, William I.; Burke, John M.; Narang, Mohit; Stevens, Don; Gray, Kathleen S.; Lutska, Yana; Bobba, Padma; Qi, Keqin; Hoehn, Daniela; Qi, Ming; Lin, Thomas S.; Rifkin, Robert M. |
| Contributors: |
Error! Hyperlink reference not valid.; Austin Horton, PhD, and Charlotte D. Majerczyk, PhD, of Cello Health Communications/MedErgy; Janssen Global Services, LLC |
| Source: |
Leukemia & Lymphoma ; volume 63, issue 10, page 2383-2392 ; ISSN 1042-8194 1029-2403 |
| Publisher Information: |
Informa UK Limited |
| Publication Year: |
2022 |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1080/10428194.2022.2076847 |
| Availability: |
https://doi.org/10.1080/10428194.2022.2076847; https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2076847 |
| Rights: |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Accession Number: |
edsbas.F20EB63A |
| Database: |
BASE |